Milrinone

This classification denotes a phosphodiesterase inhibitor with the molecular formula C12H9N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JU9YAX04C7, chemically known as 1,6-dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile but generally known as milrinone, which bears US NIH Compound Identifier 4197. European Medicines Agency schedules Milrinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08968MIG. The term MILRINONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules milrinone in its Anatomical Therapeutic Chemical (ATC) Classification. MILRINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule milrinone under HS 29337900 and SITC 51561. As of Q4 2014, MILRINONE remains the US FDA Preferred Term for this commodity. Milrinone bears US NLM identifiers UMLS ID C0128513 and NCI Concept Code C61848. SMILES: O=C1[NH]C(C(C2CCNCC2)CC1C#N)C.